Bristol-Myers to Buy Celgene in $74 Billion Cancer-Drug Bet (3)

Bristol-Myers Squibb agreed to acquire Celgene Corp. in a record-sized $74 billion deal that will unite two drugmakers battling for advantage in a crowded market for innovative cancer treatments.

BNY Mellon, JP Morgan to Pay Bondholder Class $13.5M

The Bank of New York Mellon Trust Co. and JP Morgan Trust Co. will pay $13.5 million to settle a class action with bondholders who alleged they are entitled to receive a distribution under a …

Uber Aims to Shed Troubled Past in Pre-IPO Peace-Making Bonanza

Uber Technologies Inc.’s quiet resolution of allegations that it put thousands of women at risk of sexual assault by their drivers is just the latest move by the ride-hailing giant to lessen its …